Amarantus BioScience Holdings, Inc.
AMBSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$36841
P/E Ratio—
52W High$0.0003
52W Low$0.00001
Amarantus BioScience Holdings, Inc. (AMBS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMBS · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2023Report Date: Mar 31, 2023EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Mar 31, 2023
After Market Close
AMBS reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.00 | — | $0.00B | — | — |
| ◌ Q1 FY2018 | Mar 31, 2018 | — | — | — | — | — | — |
| ◌ Q3 FY2016 | Aug 18, 2016 | — | — | — | — | — | — |
| — Q2 FY2016 | Jun 3, 2016 | — | -$0.80 | — | — | — | — |
| — Q1 FY2016 | Mar 31, 2016 | — | -$0.05 | — | — | — | — |
| ▼ Q4 FY2015 | Nov 23, 2015 | -$0.77 | -$0.98 | -27.3% | — | — | — |
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Sep 30, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2018
Mar 31, 2018
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2016
Aug 18, 2016
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2016
Jun 3, 2016
EPS Actual
-$0.80
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2016
Mar 31, 2016
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2015
Nov 23, 2015Miss
EPS Actual
-$0.98
EPS Est.
-$0.77
EPS Surpr.
-27.3%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2023 | Mar 31, 2023 | — | $0.00 | $0.00 | -10.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.00 | $0.00 | -17.65% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.00 | $0.00 | +8.82% |
| — Q2 FY2016 | Jun 3, 2016 | — | $0.06 | $0.06 | -3.23% |
| — Q1 FY2016 | Mar 31, 2016 | — | $0.05 | $0.05 | +21.22% |
| ▼ Q4 FY2015 | Nov 23, 2015 | -27.3% | $0.33 | $0.38 | +14.98% |
| ▲ Q3 FY2015 | Aug 17, 2015 | +27.5% | $3.29 | $3.13 | -4.86% |
| — Q2 FY2015 | May 20, 2015 | — | $10.43 | $8.24 | -21.00% |
Q1 FY2023-10.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2022-17.65%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2022+8.82%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2016-3.23%
Report Date
Jun 3, 2016
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q1 FY2016+21.22%
Report Date
Mar 31, 2016
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q4 FY2015+14.98%
Report Date
Nov 23, 2015
EPS Beat/Miss
-27.3%
Price Before
$0.33
Price After
$0.38
Q3 FY2015-4.86%
Report Date
Aug 17, 2015
EPS Beat/Miss
+27.5%
Price Before
$3.29
Price After
$3.13
Q2 FY2015-21.00%
Report Date
May 20, 2015
EPS Beat/Miss
—
Price Before
$10.43
Price After
$8.24
Avg Beat Reaction-4.86%
Avg Miss Reaction+14.98%
Beat Rate1 / 8 quarters
Largest Move+21.22% (Q1 FY2016)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AMBS ends December
Amarantus BioScience Holdings, Inc. (AMBS) most recently reported earnings on March 31, 2023 for Q1 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next AMBS earnings date is expected around September 1, 2026.
Each quarter, investors track AMBS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMBS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AMBS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AMBS earnings · 4 questionsAmarantus BioScience Holdings, Inc.'s next earnings report is expected around September 1, 2026. AMBS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMBS historically reports after market close (AMC).
AMBS earnings datewhen is AMBS earningsAMBS next earnings datewhen does AMBS report earningsAMBS earnings calendar
▸ Source: FMP · Amarantus BioScience Holdings, Inc. SEC filings · US GAAP · Amarantus BioScience Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026